• 
  Florent Puisset, Emmanuel Raffoux, Lionel Ades, Tony Huynh, Raphaël Itzykson, et al.. Exposure toxicity of venetoclax in acute myeloid leukemia patients in the real-life setting: impact of high exposure on delayed neutropenia. Haematologica, 2025, 110 (7), pp.1649-1653. ⟨10.3324/haematol.2024.286062⟩. ⟨hal-04920565⟩
• 
  Clémentine de la Porte Des Vaux, Corentin Provost, Anne Coste, Raoul Herbrecht, Blandine Denis, et al.. Multicenter Analysis of General presentations and Imaging features in Cerebral MUCORmycosis (MAGICMUCOR): towards different entities. Medical Mycology, 2026, 64 (1), pp.myaf122. ⟨10.1093/mmy/myaf122⟩. ⟨hal-05456570⟩
• 
  Lisa Derosa, Valerio Iebba, Carolina Alves Costa Silva, Gianmarco Piccinno, Guojun Wu, et al.. Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome. Cell, 2024, 187 (13), pp.3373-3389.e16. ⟨10.1016/j.cell.2024.05.029⟩. ⟨hal-04989274⟩
• 
  Alexandra-Cristina Paunescu, Marina Kvaskoff, Cyrille Delpierre, Lidia Delrieu, Guillemette Jacob, et al.. The influence of locus of control, coping strategies and time perspective on post-traumatic growth in survivors with primary breast cancer. BMC Psychology, 2025, 13 (1), pp.42. ⟨10.1186/s40359-025-02353-4⟩. ⟨hal-05396911⟩
• 
  Maxime Annereau, François-Xavier Legrand, Maria Virginia Sánchez-Becerra, Stéphanie Ramos, Françoise Duperray, et al.. Hospital-Compounded Birabresib Capsules for NUT Carcinoma: A Quality- and Risk-Based CMC Strategy. Pharmaceutical Research, 2026, Online ahead of print. ⟨10.1007/s11095-026-04081-9⟩. ⟨hal-05567574⟩
• 
  Katharina C. Kähler, Jessica Hassel, Mirjana Ziemer, Piotr Rutkowski, Friedegund Meier, et al.. Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma. Annals of Oncology, 2025, 36 (10), pp.1166-1177. ⟨10.1016/j.annonc.2025.06.014⟩. ⟨hal-05592592⟩
• 
  Reinhard Dummer, Georgina Long, Caroline Robert, Hussein Tawbi, Keith Flaherty, et al.. Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600–Mutant Unresectable or Metastatic Melanoma. Journal of Clinical Oncology, 2022, 40 (13), pp.1428-1438. ⟨10.1200/JCO.21.01601⟩. ⟨hal-04995197⟩
• 
  Celeste Lebbé, Nicolas Meyer, Laurent Mortier, Ivan Marquez-Rodas, Caroline Robert, et al.. Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial. Journal of Clinical Oncology, 2019, 37 (11), pp.867-875. ⟨10.1200/JCO.18.01998⟩. ⟨hal-04995183⟩
• 
  Noémie Simon-Tillaux, Aldrine Manzanilla, Thomas Filleron. Target Trial Emulation—A Unifying Approach for Causal Inference From Observational Data. JAMA Network Open, 2026, 9 (2), pp.e2558192-e2558192. ⟨10.1001/jamanetworkopen.2025.58192⟩. ⟨hal-05574287⟩
• 
  J. Hadoux, J. Hernando, K.H. Wong, C. Do Cao, H. Lasolle, et al.. Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RET. ESMO Open, 2026, 11 (3), pp.106083-106083. ⟨10.1016/j.esmoop.2026.106083⟩. ⟨hal-05574283⟩
• 
  Isabelle Ray-Coquard, Annalisa Trama, Mickael Seckl, Christina Fotopoulou, Patricia Pautier, et al.. Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting. EJSO - European Journal of Surgical Oncology, 2019, 45 (1), pp.67-74. ⟨10.1016/j.ejso.2017.09.025⟩. ⟨hal-01955062⟩
• 
  Sarah Fodil-Cherif, Julien Hadoux, Olaf Mercier, Jose Carlos Benitez, Alice Durand, et al.. Characterization, Prognosis, and Treatment of Patients With Locally Advanced or Metastatic Thymic Neuroendocrine Tumor: A Retrospective Study of the French GTE, ENDOCAN RENATEN, and RYTHMIC Networks. Journal of Thoracic Oncology, 2025, 20 (9), pp.1315 - 1327. ⟨10.1016/j.jtho.2025.04.013⟩. ⟨hal-05597835⟩
• 
  Rebecca Chapman, David Ghasemi, Felipe Andreiuolo, Valentina Zschernack, Arnault Tauziède-Espariat, et al.. Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study. Neuro-Oncology, 2023, 25 (10), pp.1871-1882. ⟨10.1093/neuonc/noad055⟩. ⟨hal-04493055⟩
• 
  Eddy Cotte, Justine Arquilliere, Pascal Artru, Jean Baptiste Bachet, Leonor Benhaim, et al.. Rectal cancer - French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR, and GRECCAR). Digestive and Liver Disease, 2025, 57 (3), pp.669-679. ⟨10.1016/j.dld.2024.12.004⟩. ⟨hal-04860940⟩
• 
  David Planchard, Benjamin Besse, Harry J.M. Groen, Sayed M.S. Hashemi, Julien Mazieres, et al.. Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis. Journal of Thoracic Oncology, 2022, 17 (1), pp.103-115. ⟨10.1016/j.jtho.2021.08.011⟩. ⟨hal-05036153⟩
• 
  D. Di Carlo, M. Annereau, M. Vignes, L. Denis, N. Epaillard, et al.. Real life data of ONC201 (Dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: results of an international academia-driven compassionate use program.. European Journal of Cancer, 2024, 216, pp.115165. ⟨10.1016/j.ejca.2024.115165⟩. ⟨hal-04893634⟩
• 
  Celine Callens, Manuel Rodrigues, Adrien Briaux, Eleonore Frouin, Alexandre Eeckhoutte, et al.. Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial. Oncogene, 2023, 42 (48), pp.3556-3563. ⟨10.1038/s41388-023-02839-8⟩. ⟨hal-05574667⟩
• 
  Romain Daillère, Bertrand Routy, Anne-Gaëlle Goubet, Alexandria Cogdill, Gladys Ferrere, et al.. Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors. OncoImmunology, 2020, 9 (1), pp.1794423. ⟨10.1080/2162402x.2020.1794423⟩. ⟨hal-03681591⟩
• 
  François de Kermenguy. Assessment of the doses received by the peripheral blood and circulating lymphocytes during radiotherapy treatments. Cancer. Université Paris-Saclay, 2024. English. ⟨NNT : 2024UPASL083⟩. ⟨tel-05585279⟩
• 
  Kausik Ray, Carlos Aguiar, Marcello Arca, Derek Connolly, Mats Eriksson, et al.. Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study. European Journal of Preventive Cardiology, 2024, 31 (15), pp.1792-1803. ⟨10.1093/eurjpc/zwae199⟩. ⟨hal-05582961⟩

3 313

2 938